The Week in Review: April 20 – April 27, 2018

Friday, April 27, 2018 News Recap: Warnings: Synthetic cannabinoids and Hepatitis A could be a fatal combination. On April 9, 2018, the Missouri Department of Health and Senior Services (DHSS) issued a news release – “Use of Synthetic Cannabinoids Linked to Severe Bleeding in the US,” informing the public about the national outbreak of bleeding illnesses among those consuming synthetic cannabinoids which appear to have been contaminated with a long-...

Pilot program connects Vancouver immigrant communities with hepatitis C treatment

On the second floor of an immigrant settlement agency in Richmond, B.C., Gigi Lo delivered her first presentation on hepatitis C and HIV to a class of English as a Second Language students Wednesday. The United Chinese Community Enrichment Services Society, or SUCCESS, sits in a new building near the Richmond Centre mall. That day, late spring sunshine poured into the classroom through its floor-to-ceiling windows. Delivering communicable disease educa

SOVALDI Webinar slides – Link to Dr Ramji July 3 presentation

Link to July 3, 2014 WEBINAR about Sovaldi by Dr. Alnoor Ramji, co-hosted by HepCBC and the Pacific Hepatitis C Network. You just need to type in your name, email, etc. - no PW required. This webinar will only be online through July 14, 2014. To submit your voice to the Sovaldi (sofosbuvir) heptitis C drug review, please go to this page: http://hepcbc.ca/2014/07/sovaldi-bc/ . Sovaldi is produced by Gilead Sciences.